Phyllis J. Goodman
- Pulmonary and Respiratory Medicine top 0.1%
- Oncology top 0.5%
- Molecular Biology top 5%
- Surgery top 1%
- Cancer Research top 0.5%
- Co-authors
- Ian M. ThompsonCatherine M. TangenM. Scott LuciaCharles A. ColtmanScott M. LippmanHoward L. ParnesLeslie G. FordLori M. Minasian
- Topics
- Prostate Cancer Treatment and Research (68 papers)Prostate Cancer Diagnosis and Treatment (56 papers)Antioxidant Activity and Oxidative Stress (23 papers)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Phyllis J. Goodman
154 papers receiving 12.7k citations
Hit Papers
Peers
Comparison fields: 5 of 160
- Pulmonary and Respiratory Medicine 6.8k
- Oncology 3.5k
- Molecular Biology 2.3k
- Surgery 2.0k
- Cancer Research 1.9k
Countries citing papers authored by Phyllis J. Goodman
This map shows the geographic impact of Phyllis J. Goodman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phyllis J. Goodman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phyllis J. Goodman more than expected).
Fields of papers citing papers by Phyllis J. Goodman
This network shows the impact of papers produced by Phyllis J. Goodman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phyllis J. Goodman. The network helps show where Phyllis J. Goodman may publish in the future.
Co-authorship network of co-authors of Phyllis J. Goodman
This figure shows the co-authorship network connecting the top 25 collaborators of Phyllis J. Goodman. A scholar is included among the top collaborators of Phyllis J. Goodman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phyllis J. Goodman. Phyllis J. Goodman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 7 | |
| 5 | 4 | |
| 6 | 4 | |
| 7 | 2 | |
| 8 | 47 | |
| 9 | 49 | |
| 10 | 181 | |
| 11 | 28 | |
| 12 | 133 | |
| 13 | 72 | |
| 14 | 140 | |
| 15 | 6 | |
| 16 | 2 | |
| 17 | 217 | |
| 18 | 4 | |
| 19 | 3 | |
| 20 | A phase II trial of recombinant tumor necrosis factor in patients with metastatic colorectal adenocarcinoma: a Southwest Oncology Group study. | 21 |
About Phyllis J. Goodman
Phyllis J. Goodman is a scholar working on Biochemistry, Pulmonary and Respiratory Medicine and Statistics and Probability, having authored 160 papers that have together received 13.2k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (68 papers), Prostate Cancer Diagnosis and Treatment (56 papers) and Antioxidant Activity and Oxidative Stress (23 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (6.8k citations), Urology (1.2k citations) and Oncology (3.5k citations). Phyllis J. Goodman has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Ian M. Thompson, Catherine M. Tangen, M. Scott Lucia, Charles A. Coltman, Scott M. Lippman, Howard L. Parnes, Leslie G. Ford, Lori M. Minasian, Alan R. Kristal and John J. Crowley. Their work appears in journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.